Methylenetetrahydrofolate Reductase Gene rs1801133 and rs1801131 Polymorphisms and Essential Hypertension Risk: A Comprehensive Analysis
- PMID: 35284002
- PMCID: PMC8888071
- DOI: 10.1155/2022/2144443
Methylenetetrahydrofolate Reductase Gene rs1801133 and rs1801131 Polymorphisms and Essential Hypertension Risk: A Comprehensive Analysis
Abstract
Background: Essential hypertension (EH) is a common and multifactorial disorder that is likely to be influenced by multiple genes. The methylenetetrahydrofolate reductase (MTHFR) gene rs1801133 and rs1801131 polymorphisms influence MTHFR enzyme activity and plasma homocysteine concentration. In addition, variations in MTHFR functions likely play roles in the etiology of EH. Thus far, a large number of studies investigating the associations between the MTHFR polymorphisms and EH have provided controversial or inconclusive results. To better assess the purported relationship, we performed a comprehensive analysis of 52 published studies. Objective and Methods. Eligible studies were identified by searching the PubMed, Wanfang, and China National Knowledge Infrastructure (CNKI) databases. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated to assess the potential association between the MTHFR rs1801133 polymorphism and EH.
Results: Overall, 10712 patients and 11916 controls were involved; we observed significantly increased association between the MTHFR rs1801133 polymorphism and EH risk (such as T vs. C: OR = 1.38, 95% CI = 1.25 - 1.54, P ≤ 0.001), with similar results evident within race subgroups (such as Asian: T vs. C: OR = 1.47, 95% CI = 1.30 - 1.67, P ≤ 0.001; compared to Chinese: T vs. C: OR = 1.54, 95% CI = 1.33 - 1.79, P ≤ 0.001). Similar associations were also found in subgroups defined by the source of controls and genotype methods. To our regret, based on the limited studies, no association was detected for rs1801131 polymorphism.
Conclusions: Our study provides evidence that the MTHFR rs1801133 null genotype may increase EH risk. Future studies with larger sample sizes are warranted to evaluate this association in more detail.
Copyright © 2022 Yingchao Fan et al.
Conflict of interest statement
The authors declare no conflict of interest.
Figures











Similar articles
-
Associations of methylenetetrahydrofolate reductase gene (MTHFR) rs1801131 and rs1801133 polymorphisms with susceptibility to vitiligo: A meta-analysis.J Cosmet Dermatol. 2021 Jul;20(7):2359-2368. doi: 10.1111/jocd.13857. Epub 2020 Dec 3. J Cosmet Dermatol. 2021. PMID: 33219596
-
The roles of MTRR and MTHFR gene polymorphisms in congenital heart diseases: a meta-analysis.Biosci Rep. 2018 Dec 7;38(6):BSR20181160. doi: 10.1042/BSR20181160. Print 2018 Dec 21. Biosci Rep. 2018. PMID: 30333252 Free PMC article.
-
Genetic polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR) and risk of vitiligo in Han Chinese populations: a genotype-phenotype correlation study.Br J Dermatol. 2014 May;170(5):1092-9. doi: 10.1111/bjd.12845. Br J Dermatol. 2014. PMID: 24472005
-
Associations of MTHFR rs1801133 (677C>T) and rs180113 (1298A>C) Polymorphisms with Susceptibility to Bladder Cancer: A Systematic Review and Meta-Analysis.Asian Pac J Cancer Prev. 2022 May 1;23(5):1465-1482. doi: 10.31557/APJCP.2022.23.5.1465. Asian Pac J Cancer Prev. 2022. PMID: 35633528 Free PMC article.
-
Association Between MTHFR Polymorphisms and the Risk of Essential Hypertension: An Updated Meta-analysis.Front Genet. 2021 Nov 26;12:698590. doi: 10.3389/fgene.2021.698590. eCollection 2021. Front Genet. 2021. PMID: 34899823 Free PMC article. Review.
Cited by
-
Susceptibility to hypertension based on MTHFR rs1801133 single nucleotide polymorphism and MTHFR promoter methylation.Front Cardiovasc Med. 2023 Oct 2;10:1159764. doi: 10.3389/fcvm.2023.1159764. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37849939 Free PMC article.
-
Genetic variants and mRNA expression levels of KLF4 and KLF5 with hypertension: A combination of case-control study and cohort study.J Biomed Res. 2024 Aug 27;39(1):103-113. doi: 10.7555/JBR.38.20240208. J Biomed Res. 2024. PMID: 39187911 Free PMC article.
-
Widespread recessive effects on common diseases in a cohort of 44,000 British Pakistanis and Bangladeshis with high autozygosity.Am J Hum Genet. 2025 Jun 5;112(6):1316-1329. doi: 10.1016/j.ajhg.2025.03.020. Epub 2025 Apr 29. Am J Hum Genet. 2025. PMID: 40306283 Free PMC article.
-
A controlled comparative study of the effects of methotrexate and pharmacogenetic factors on arterial blood pressure and arterial stiffness in patients with rheumatoid arthritis.Ann Med. 2025 Dec;57(1):2539311. doi: 10.1080/07853890.2025.2539311. Epub 2025 Jul 31. Ann Med. 2025. PMID: 40742006 Free PMC article. Clinical Trial.
-
Effect of methylenetetrahydrofolate reductase C677T polymorphism on serum folate but not vitamin B12 levels in patients with H-type hypertension.Mol Biol Rep. 2022 Oct;49(10):9535-9541. doi: 10.1007/s11033-022-07844-w. Epub 2022 Aug 11. Mol Biol Rep. 2022. PMID: 35951145
References
-
- Petramala L., Acca M., Francucci C. M., D'Erasmo E. Hyperhomocysteinemia: a biochemical link between bone and cardiovascular system diseases? Journal of Endocrinological Investigation . 2009;32(4 Suppl):10–14. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources